Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Sanofi

Are these the most corporate Olympics ever?

It’s rather exceptional that a G7 Olympic host gets the support of so many of its largest companies.

Fortune

Can I take antihistamines everyday? More than the recommended dose? What if I’m pregnant? Here’s what the research says

Allergies happen when your immune system overreacts to a normally harmless substance like dust or pollen. Hay fever, hives and anaphylaxis are all types of allergic reactions.

The Conversation

The secrets of success with Paul Hudson, CEO of Sanofi

Today we meet with British CEO Paul Hudson to find out how he plans to build the Sanofi of tomorrow.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Usher and Apple CEO Tim Cook had a meeting. Now the Super Bowl performer is taking his ideas to Capitol Hill

Usher will join French pharma giant Sanofi in Washington, D.C., to discuss the importance of early screening for type 1 diabetes.

Fortune

Sanofi’s CEO thinks OpenAI offers 'insane' potential for the pharmaceutical industry

Sanofi CEO Paul Hudson thinks AI offers 'insane' potential for the pharmaceutical industry, which can spend up to $4 billion developing a drug.

Fortune

Sanofi Allies With OpenAI, Formation Bio For AI Use In Drug Development

French pharmaceutical company Sanofi announced Tuesday a partnership with ChatGPT-founder OpenAI and US biotech firm Formation Bio to accelerate the use of artificial intelligence in developing drugs.

International Business Times

‘The issue is when to pull the trigger’: how prepared are we for human bird flu?

The H5N1 virus has been devastating bird populations, and is now infecting mammals too. Is human-to-human transmission next? And are we ready for another pandemic?

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Stock Market Today: Stocks End Mixed on the Day, Higher on the Week

The latest consumer sentiment data showed inflation concerns are on the rise.

Kiplinger

Novavax strikes $1.2 billion deal with Sanofi in major turnaround

It's a major turnaround for a drug company that warned last year about its ability to stay in business.

Axios

French, US Drug Firms Team Up For Covid-flu Shot

French pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines with a flu shot.

International Business Times

What is behind the insulin shortage in the US?

Pharma companies are slashing insulin production in favour of more lucrative weight-loss drugs.

Al Jazeera

Sanofi To Revamp US Vaccine Operations, Reduce Workforce

Sanofi restructures US vaccine operations to drive growth and maintain competitiveness in the pharmaceutical market.

Top News

Sanofi gets approval for alternative inactivated polio vaccine

Only recently, activists, public health experts, tuberculosis (TB) survivors, and people living with HIV had sought Prime Minister Narendra Modi’s intervention to halt what they said were frequent shortages in the availability of anti-TB drugs.

The Hindu

Sanofi To Settle Around 4,000 Suits Over Zantac Cancer Allegations

Sanofi will settle around 4,000 claims alleging its heartburn medication, Zantac, is linked to cancer.

International Business Times

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Top 3 Pharma Innovators to Watch Closely

The pharmaceutical industry is experiencing considerable growth, driven by rising healthcare needs, continuous advances in drug discovery & discovery, and M&A activity. So, investors could keep a close eye on top pharma stocks Amneal Pharmaceuticals (AMRX), Collegium Pharmaceutical (COLL), and Sanofi (SNY) for potential gains. Keep reading….

StockNews.com

Navigate to Success With These 4 Pharma Stocks to Buy

The pharmaceutical industry is expanding due to increased demand for healthcare products and technological advancements. Therefore, fundamentally strong pharma stocks Kamada (KMDA), Hypera (HYPMY), Eli Lilly (LLY) and Sanofi (SNY) might be ideal additions to your portfolio. Read on.

StockNews.com

4 Sky-Rocketing Pharma Stocks to Watch

The pharmaceutical industry is experiencing significant growth due to the rising demand for quality healthcare and high-quality drugs. This surge is further supported by the rapid growth in the global elderly population and the increase in chronic illnesses. Therefore, investors could consider adding pharma stocks Spero Therapeutics (SPRO), Wave Life…

The Guardian - UK

The mothers fighting a scandal bigger than thalidomide: ‘We were told the medication was safe’

Since the 1970s, it has been known that sodium valproate can harm babies in the womb. So why was it prescribed to pregnant women?

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

5 Pharma Stocks to Watch With Bullish Momentum

The pharma industry is poised for robust expansion this year with rising demand and technological advancement in the sector. Hence, investors might watch fundamentally solid pharma stocks Procaps Group (PROC), Sanofi (SNY), Viatris (VTRS), Ipsen (IPSEY), and Teva Pharmaceutical Industries (TEVA) for solid gains. Read on.

StockNews.com

3 B-Rated Pharma Stocks to Secure Now With Great Value

The pharmaceutical industry, which experienced significant growth over the past years, is anticipated to remain buoyed, driven by the increasing prevalence of chronic diseases, advancements in medical technology, and rising healthcare awareness and expenditure. Given this backdrop, quality pharma stocks Voyager Therapeutics (VYGR), Sanofi (SNY), and Pacira BioSciences (PCRX), with…

Fortune

Gen X drugmaker is coughing up millions for Paris Olympics sponsorship to show Gen Z and millennials it's a cool place to work

Sanofi is hoping the exposure will help put the brand in front of prospective young talent which it has struggled to recruit.

Kiplinger

Insulin Now Available for $35 a Month for Many Americans

Insulin price caps from Eli Lilly, Novo Nordisk and Sanofi take effect this month.

Top News

Insulin prices to drop after manufacturers cap costs

Good news for Americans with diabetes as Sanofi becomes the third major insulin manufacturer to cap costs at per month, reducing financial strain and i...

Radio France Internationale

Pharmaceutical plant found to have leaked neurotoxin in south-western France

A Sanofi pharmaceutical plant in the south west of France has been found to have discharged large quantities of the bromopropane neurotoxin into the atmosphere in mid-November.

Fortune

How the high-stakes world of Formula 1 racing inspired Sanofi CEO Paul Hudson to deliver more medicines

Hudson sought to emulate the efficiency of a race car team that recently set the world record for quickest pit stop.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.